DCF — ST. JOSEPH MEDICAL CENTER
Enterprise Value: $396.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$396.5M
Enterprise Value
$108.4M
PV of Cash Flows
$288.1M
PV of Terminal Value
$464.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $344.8M | $47.3M | 14.0% | $23.1M | $21.0M |
| Year 2 | $355.2M | $52.3M | 15.0% | $26.4M | $21.8M |
| Year 3 | $365.8M | $57.5M | 16.0% | $29.9M | $22.5M |
| Year 4 | $376.8M | $61.1M | 16.0% | $32.3M | $22.0M |
| Year 5 | $388.1M | $63.9M | 16.0% | $34.0M | $21.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $396.5M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$334.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13226323654319663
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5